請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/20377完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 王秀伯,鄭祖耀 | |
| dc.contributor.author | Min-Horn Tsai | en |
| dc.contributor.author | 蔡明宏 | zh_TW |
| dc.date.accessioned | 2021-06-08T02:46:45Z | - |
| dc.date.copyright | 2017-09-12 | |
| dc.date.issued | 2017 | |
| dc.date.submitted | 2017-08-21 | |
| dc.identifier.citation | 1.Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining the impact on quality of life. Gastrointest Endosc.56:835-841, 2002.
2.Ballinger AB, McHugh M, Catnach SM, et al. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994;35: 467-70. 3.Bezzi M, Zolovkins A, Cantisani V, et al. New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction. J Vasc Interv Radiol 2002; 13:581–589. 4.Boguth L, Tatalovic S, Antonucci F, Heer M, Sulser H, Zollikofer CL. Malignant biliary obstruction: clinical and histopathologic correlation after treatment with self-expanding metal prostheses. Radiology 1994; 192:669–674. 5.Boyce JM, Havill NL, Maria B. Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005 Dec;43(12):5992-5. 6.Cote GA, Kumar N, Ansstas M, et al. Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc 2010;72:748-54. 7.Hatzidakis AA, Tsetis D, Chrysou E, Sanidas E, Petrakis J, Gourtsoyiannis NC. Nitinol stents for palliative treatment of malignant obstructive jaundice: should we stent the sphincter of Oddi in every case? Cardiovasc Intervent Radiol 2001; 24:245–248. 8.Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc. 38:341-346, 1992. 9.Kaassis M, Boyer J, Dumas R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 57:178-182, 2003. 10.Kaskarelis IS, Minardos IA, Abatzis PP, et al. Percutaneous metallic self-expandable endoprostheses in biliary obstruction caused by metastatic cancer. Hepatogastroenterology 1996; 43:785–791. 11.Kullman E, Frozanpor F, Soderlund C, et al. Covered vs. uncovered selfexpandable nitinol stents I the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc 2010;72:915-23. 12.Lameris JS, Stoker J, Nijs HG, et al. Malignant biliary obstruction: percutaneous use of self-expandable stents. Radiology 1991; 179:703–707V. 13.Lawson AJ, Beningfield SJ, Krige JE, Rischbieter P, Burmeister S. Percutaneous transhepatic self-expanding metal stents for palliation of malignant biliary obstruction. S Afr J Surg. 2012 Jul 11;50(3):54, 56, 58 passim. 14.Lee TH. Technical tips and issues of biliary stenting, focusing on malignant hilar obstruction. Clin Endosc. 2013 May;46(3):260-6. doi: 10.5946/ce.2013.46.3.260. 15.Li Sol Y, Kim CW, Jeon UB, Lee NK, Kim S, Kang DH, Kim GH. Early infectious complications of percutaneous metallic stent insertion for malignant biliary obstruction. AJR Am J Roentgenol. 2010 Jan;194(1):261-5. 16.Moss AC, Morris E, Leyden J, et al. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 19:1119-1124, 2007. 17.Nicholson AA, Royston CM. Palliation of inoperable biliary obstruction with self-expanding metal endoprostheses: a review of 77 patients. Clin Radiol 1993; 47:245–250. 18.Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 47:1-7, 1998. 19.Stoker J, Lameris JS. Complications of percutaneously inserted biliary Wallstents. J Vasc Interv Radiol 1993; 4:767–772. 20.Suk KT, Kim HS, Kim JW, et al. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest Endosc 2006; 64:522–529. 21.Telford JJ, Carr-Locke DL, Baron TH, et al. A randomized controlled trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction Gastrointest Endosc 2010;72:907-14. 22.Yeoh KG, Zimmerman MJ, Cunningham JT, et al. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc. 49:466-471, 1999. 23.Zimmer V, Lammert F. Acute bacterial cholangitis. Viszeralmedizin. 2015 Jun;31(3):166-72. doi: 10.1159/000430965. Epub 2015 Jun 11. Review. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/20377 | - |
| dc.description.abstract | 惡性腫瘤會造成許多併發症，包括膽道阻塞併發黃疸。阻塞性黃疸的相關症狀包刮皮膚癢、噁心、食慾低落、發燒、傷口癒合延遲、生活品質下降等。惡性膽道阻塞通常在癌症的晚期或末期發生。緩解惡性膽道阻塞除了改善病人的生活品質，還能降低醫療支出。目前可以經由內視鏡逆行性或經皮順行性置放膽道金屬支架進行膽道引流，不只成功率高，也能維持較久的時間。但目前僅有少數的研究比較這兩種不同的方式所造成的副作用。因此，此研究是針對這兩種方式所引發的相關併發症，包括感染、支架位移、支架阻塞、胰臟炎、膽囊炎等，進行比較及探討。 | zh_TW |
| dc.description.abstract | Malignant tumors may cause a variety of complications including malignant biliary obstruction related jaundice. The symptoms of obstructive jaundice such as pruritus, nausea, loss of appetite, fever, delayed wound healing, decrease patient’s quality of life significantly. Usually malignant biliary obstruction will develop in the advanced or terminal cancer stage. Relieving malignant biliary obstruction not only improves patient’s quality of life but also decreases medical cost. Currently, both endoscopic retrograde and percutaneous antegrade biliary drainage could achieve high successful rates and maintain longer duration. But few studies compare the adverse effect of the two methods. The aim of this study is to compare the adverse effect of the two methods, including infection, stent migration, stent occlusion, pancreatitis, cholecystitis, etc. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T02:46:45Z (GMT). No. of bitstreams: 1 ntu-106-P04421012-1.pdf: 485520 bytes, checksum: 38274442585b31f2359a717439c24cf6 (MD5) Previous issue date: 2017 | en |
| dc.description.tableofcontents | 誌謝………………………………………………………………… i
中文摘要……………………………………………………...… ii 英文摘要………………………………………………………… iii 碩士論文內容 Introduction…………………..…..........………………… 1 Materials and Methods………………..............…… 3 Results…………………………………………………………. 4 Discussion ………………………………………………..... 6 Prospective…………………………………….....………… 9 Summary……………………………………………………… 10 參考文獻………………………………………………………… 11 Table 1………………………………………….........……... 13 Table 2…………………………………………………........ 14 Table 3………………………………………………...……… 15 Table 4…………………………………………………...…… 16 Table 5……………………………………………………....… 17 Figure 1……………………………………………………...... 18 | |
| dc.language.iso | zh-TW | |
| dc.title | 惡性膽道阻塞接受內視鏡逆行性和經皮穿肝順行性金屬支架置放的併發症比較 | zh_TW |
| dc.title | Comparison of adverse effects after metallic stenting for malignant biliary obstruction between endoscopic retrograde and percutaneous transhepatic antegrade routes | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 105-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 楊宏志 | |
| dc.subject.keyword | 惡性膽道阻塞,膽道金屬支架,內視鏡逆行性膽道支架置放術,經皮穿肝膽管引流,併發症, | zh_TW |
| dc.subject.keyword | malignant biliary obstruction,biliary metal stent,endoscopic retrograde biliary drainage,percutaneous transhepatic cholangial drainage,complication, | en |
| dc.relation.page | 18 | |
| dc.identifier.doi | 10.6342/NTU201704134 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2017-08-21 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
| 顯示於系所單位： | 臨床醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-106-1.pdf 未授權公開取用 | 474.14 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。